Dr. Mark R. Olsen, MD, PhD

Dr. Mark R. Olsen, MD, PhD

Medical Oncologist

Accepting new patients

4.7 out of 5 on Google

Specialties

  • Brain/Eye
  • Digestive/Gi
  • Head And Neck
  • Male Genital/Gu
  • Melanoma/Skin Cancer

Locations

Tulsa

12697 East 51st Street South, Tulsa, OK 74146

View location

About

Dr. Mark R. Olsen received his doctoral degree in oncology from the McArdle Laboratory for Cancer Research at the University of Wisconsin and a medical degree from the University of Wisconsin Medical School. He completed his internal medicine residency, a three-year fellowship in medical oncology and a two-year fellowship in neuro-oncology at the University of Wisconsin Hospital and Clinics. Dr. Olsen is a co-author of articles and abstracts. He has given presentations on cancer prevention, breast cancer, gastric lymphoma, brain tumors, and chronic myelogenous leukemia. He specializes in clinical research, hematology, and medical oncology.

Training & Education

Book an Appointment

Schedule your visit with our care team

Choose the option below to book an appointment. Existing patients can access the secure portal, and new patients can call our team to get started.

Existing Patient

Sign in to your patient portal to request, confirm, or manage an appointment.

Open Patient Portal

New Patient

Call our scheduling team to book your first appointment and receive next-step guidance.

Call: (918) 505-3200

Explore Our Care

Discover services, specialists, and research

Learn more about the comprehensive cancer care available at OCSRI — from expert providers and convenient locations to advanced treatment services and ongoing clinical research.

Privacy Choices

Cookie and Tracking Consent

Oklahoma Cancer Specialists and Research Institute uses cookies and similar tracking technologies to keep this site functioning and, with your permission, to measure traffic and improve the experience. By clicking Accept, you consent to analytics and tracking cookies. By clicking Decline, only essential site functionality will remain enabled.

See our Privacy Policy for more information.